<~-- -->
Clinical Research Advantage, Inc.
, (CRA), a provider of a range of research services to pharmaceutical companies and clinical research organizations (CROs), announced its expansion into the Colorado Springs market with the opening of two local area offices.
CRA has forged a partnership with a medical practice in the area whose physicians serve as principal investigators of the clinical trials it manages and oversees. As a trial management organization (TMO), CRA helps clinical trial sponsors bring drugs to market more quickly and efficiently. CRA offers a mechanism for medical professionals to conduct phase II-IV clinical research trials. CRA is comprised of dozens of community-based investigators based throughout the country.
Local CRA offices in Colorado Springs include one at Colorado Springs Health Partners in Briargate—2405 Research Parkway in Briargate (office of Kari Uusinarkaus, M.D.; Dennis Schneider, M.D. and Gordon Golden, M.D.); and on the east side at 6340 Barnes Road (office of John Speer, M.D., Max Nevarez, M.D., Royce Solano, M.D. and Alan Garscadden, M.D.).
Current plans call for several more sites to open in the Colorado Springs area by summer 2011.
The new offices and principal investigators focus on trials and maintenance studies relating to the various diagnoses as well as others within the realm of family and internal medicine. At Briargate, studies underway include irritable bowel syndrome-diarrhea, hypercholesterolemia, Type II Diabetes Naïve (not currently being treated with anti-diabetic medication) and acute coronary syndrome with or without Type II Diabetes. Upcoming studies include Type II Diabetes and hypertriglyceridemia. At the east office, studies being conducted include those for chronic obstructive pulmonary disease, irritable bowel syndrome-diarrhea, pediatric influenza vaccine, and Type II Diabetes with cardiovascular risk. Upcoming studies at this office include opioid-induced constipation and Type II diabetes.
Concurrent with the office openings, CRA named Monica Garcia, BS, CCRC, to the post of region manager. Garcia heads the Colorado Springs-area operations and has worked with CRA for the past six years. She is certified through the Association of Clinical Research Professionals , an industry trade organization that serves as a resource for clinical research professionals engaged in the pharmaceutical, biotechnology and medical device industries, and those in hospital, academic medical centers and physician office settings.
Since CRA was acquired in 2007 by Mark Hanley, who serves as chief executive officer, and David Bruggeman, president and chief operating officer, the company has grown from six to 23 sites, doubled the number of employees and substantially increased the revenue base.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.